The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influential factors impacting treatment (tx) decision making (TDM) and decision regret (DR) in patients (pts) with localized or locally advanced prostate cancer (LPC/LAPC).
 
Benjamin Adam Gartrell
Honoraria - Janssen
Consulting or Advisory Role - Janssen
 
Angaja Phalguni
No Relationships to Disclose
 
Suneel Mundle
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Sharon McCarthy
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Sabine D. Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Honoraria - Wellster Healthtech Group
Consulting or Advisory Role - Wellster Healthtech Group
Patents, Royalties, Other Intellectual Property - Founder of Vitruvo eHealth and Developer of a Digital Medicine Application
 
Francesco De Solda
Employment - Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene (I); Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene (I); Johnson & Johnson/Janssen
 
Ruhee Jain
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Guillaume Ploussard
Honoraria - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen Oncology; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen Oncology; Sanofi Pasteur
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Ipsen; Janssen